CPI-203

CAS No. 202591-23-9

CPI-203( —— )

Catalog No. M13155 CAS No. 202591-23-9

CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
5MG 29 In Stock
10MG 43 In Stock
25MG 68 In Stock
50MG 124 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CPI-203
  • Note
    Research use only, not for human use.
  • Brief Description
    CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
  • Description
    CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    BRD4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    202591-23-9
  • Formula Weight
    399.9
  • Molecular Formula
    C19H18ClN5OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 200 mM
  • SMILES
    CC1=C(C)C2=C(S1)N1C(C)=NN=C1C(CC(N)=O)N=C2C1=CC=C(Cl)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Devaiah BN, et al. Proc natl Acad Sci U S A. 2012, 109(18), 6927-6932.
molnova catalog
related products
  • Cyclogalegenol

    Astramembrangenin (Cycloastragenol) is a triterpenoid saponin compound and a hydrolysis product of the main active ingredient in Astragalus membranaceus.?Cycloastragenol (CAG) may have a novel therapeutic role in depression.

  • BRD4 Inhibitor-20

    BRD4 Inhibitor-20 is a potent bromodomain protein 4 (BRD4) inhibitor with oral activity, demonstrating antiproliferative effects in cancer cell lines and used in studies of various cancers, including colon cancer.

  • PFI-1

    PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM in a cell-free assay.